PlumBot: Bot: Creating new article from JSON

2026-03-11T07:01:07Z

Bot: Creating new article from JSON

New page

💰 '''Extraordinary dividend approval''' is the regulatory authorization that an [[Definition:Insurance carrier | insurance carrier]] must obtain from its domiciliary [[Definition:State insurance department | state insurance department]] before paying a dividend or distribution that exceeds statutory thresholds. Most U.S. jurisdictions define an extraordinary dividend as one that, together with other distributions made within the preceding twelve months, surpasses the greater of 10 percent of the insurer's [[Definition:Statutory surplus | statutory surplus]] or the prior year's [[Definition:Net income (statutory) | statutory net income]]. Because insurance companies hold capital in trust for [[Definition:Policyholder | policyholders]], regulators treat large outflows of surplus with heightened caution — especially when those outflows are driven by parent-company financing needs during a [[Definition:Merger (insurance) | merger]] or [[Definition:Acquisition (insurance) | acquisition]].

⚙️ The process typically begins when the insurer's board of directors resolves to declare the dividend and files a formal notice with the regulator, often 30 days or more before the intended payment date. The filing includes pro forma financial statements showing the company's [[Definition:Risk-based capital (RBC) impact | RBC position]] after the distribution, details of any recent [[Definition:Affiliated transaction | affiliated transactions]], and an explanation of the business purpose. Regulators evaluate whether the payment would impair the insurer's ability to meet [[Definition:Loss reserve | claim obligations]], maintain adequate capital margins, and honor [[Definition:Reinsurance | reinsurance]] commitments. In contested cases — particularly those involving [[Definition:Private equity (insurance) | private equity]]–backed holding companies seeking to upstream cash — the regulator may impose conditions, require a reduced amount, or deny the request outright.

🔍 Deal architects ignore this approval step at their peril. In many insurance M&A transactions, the buyer's financial model depends on extracting a pre-close or post-close dividend from the target to recoup part of the purchase price or service [[Definition:Acquisition financing | acquisition debt]]. A denial or delay from the regulator can blow a hole in projected returns and alter the economics of the entire deal. Sophisticated buyers therefore engage with regulators early — sometimes on a pre-filing, informal basis — to gauge receptivity and structure the dividend in a way that preserves the insurer's [[Definition:Capital adequacy (insurance) | capital adequacy]]. This step has grown even more consequential as regulators have sharpened their focus on distributions from insurers within complex [[Definition:Insurance holding company system | holding company systems]].

'''Related concepts:'''
{{Div col|colwidth=20em}}
* [[Definition:Statutory surplus]]
* [[Definition:Risk-based capital (RBC) impact]]
* [[Definition:Insurance holding company system]]
* [[Definition:Ordinary dividend (insurance)]]
* [[Definition:Affiliated transaction]]
* [[Definition:Policyholder protection (M&A)]]
{{Div col end}}

Definition:Extraordinary dividend approval - Revision history

PlumBot: Bot: Creating new article from JSON